PDE5 inhibitor
Tadalafil
Brand names: Cialis, Adcirca
Adult dose
Dose: ED PRN: 10–20mg PO 30min before sex. ED daily: 2.5–5mg OD. BPH: 5mg OD. PAH: 40mg OD
Route: PO
Frequency: PRN or OD
Dose adjustments
Renal
Reduce in severe renal impairment
Clinical pearls
- Long half-life (~17.5h) — 'weekend pill'
- BPH + ED combination indication
Contraindications
- Concurrent nitrates
- Recent MI/stroke (≤90d)
- Severe hepatic impairment
- Severe hypotension
- Hereditary degenerative retinal disorders
Side effects
- Headache
- Flushing
- Dyspepsia
- Nasal congestion
- Back pain
- Priapism
- NAION
- Hearing loss
Interactions
- Nitrates (avoid)
- α-blockers
- Strong CYP3A4 modulators
- Riociguat (avoid)
Reference: BNF; NICE CG97; ESC; https://bnf.nice.org.uk/drugs/tadalafil/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- SMART Risk Score for Recurrent CVD · Cardiovascular Risk
- PCSK9 Inhibitor Eligibility Assessment · Lipid Management
- Immune-Related Adverse Events (irAE) -- GI Toxicity Colitis Grading · Oncology-Related GI
- irAE Hepatitis Grading (CTCAE) · Immunotherapy
- DIPSS — Dynamic International Prognostic Scoring System for Myelofibrosis · Cancer Prognosis
- BALL Score for Relapsed/Refractory CLL · Leukaemia